ATS 2020 Advance Program

CLINICAL POSTGRADUATE COURSE PG19 INTERSTITIAL LUNG DISEASE: UPDATE AND EVOLVING TRENDS IN DIAGNOSIS AND MANAGEMENT Pre-registration and additional fees required. Continental breakfast and box lunch included. Attendance is limited. Member: $350 In-Training Member: $200 Non-Member: $425 In-Training Non-Member: $300 Assemblies on Clinical Problems; Allergy, Immunology and Inflammation; Behavioral and Health Services Research; Environmental, Occupational and Population Health; Nursing; Pulmonary Rehabilitation 8:00 a.m. - 4:00 p.m. Target Audience Clinicians, nurses,other allied health staff, researchers and investigators in basic and clinical fields of interstitial lung disease, and sponsors for research. Objectives At the conclusion of this session, the participant will be able to: • accurately diagnose patients with specific forms of interstitial lung disease, even those without clear radiologic or histopathologic patterns; • gain additional tools to improve quality of life and symptom management among patients with advanced interstitial lung disease; • gain increased competence to provide evidence based care to patients with ILD and will also have increased comfort in discussing available clinical trials and recent research and clinical developments with colleagues and patients. This course will provide an update on diagnosis and management of interstitial lung diseases (ILDs) of unknown etiology as well as ILD in the setting of connective tissue disease, vasculitis, and environmental exposures. The course will start with an overview and introduction to ILD with an approach to diagnosis. Trends in imaging and histopathology will be reviewed. Idiopathic pulmonary fibrosis, cystic lung disease, granulomatous ILD (HP) are among the diseases that will be discussed. Live discussion between a panel of experts (pulmonology, radiology, pathology, rheumatology) reviewing cases unknown to them (clinical history, imaging, histopathology) will illustrate the importance of multi disciplinary discussion in making an accurate diagnosis of the specific ILD. Chairing: G. Raghu, MD, Seattle, WA L. Richeldi, PhD, MD, Rome, Italy B. Collins, MD, Seattle, WA 8:00 Introduction G. Raghu, MD, Seattle, WA 8:05 ILD Overview and Approach to Diagnosis B. Collins, MD, Seattle, WA 8:25 ILD Pathogenesis: From Mice to Men M.R.J. Kolb, PhD, MD, Hamilton, Canada 8:45 Imaging for ILD: Patterns, Distribution and Clues for Diagnosis and Prime Time for Machine Learning Tools D.A. Lynch, MBBCh, Denver, CO 9:05 Histopathologic Patterns of Idiopathic Interstitial Pneumonias and Granulomatous Interstitial Lung Diseases J.L. Myers, MD, Ann Arbor, MI 9:25 Lung Biopsy for Histopathology for Diagnosis of ILD: Risks and Benefits of Cryobiopsy and Surgical Lung Biopsy - Lessons Learned L.K. Troy, PhD, MBBS, BMedSci, Sydney, Australia 9:45 Cutting Edge Diagnostic Modalities in ILD: Molecular Classifier and Biomarkers M. Kreuter, MD, Heidelberg, Germany 10:05 Break 10:20 Connective Tissue Disease ILD: Role of Serology in Diagnosis and Role of Immune Modulating Agents and Antifibrotics for Treatment M.E. Strek, MD, ATSF, Chicago, IL 10:40 Role of Genetic Testing in Diagnosis, Treatment, and Prognosis of ILD B. Crestani, MD, PhD, Paris, France ATS 2020 • Philadelphia, PA SATURDAY • MAY 16 23